![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 26, 19752-19758, June 30, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Department of Microbiology and Immunology, University of
North Carolina, Chapel Hill, North Carolina 27599-7290
Received for publication, December 10, 1999, and in revised form, March 23, 2000
In Escherichia coli, swimming
behavior is mediated by the phosphorylation state of the response
regulator CheY. In its active, phosphorylated form, CheY exhibits
enhanced binding to a switch component, FliM, at the flagellar motor,
which induces a change from counterclockwise to clockwise flagellar
rotation. When Ile95 of CheY is replaced by a valine,
increased clockwise rotation correlates with enhanced binding to FliM.
A possible explanation for the hyperactivity of this mutant is that
residue 95 affects the conformation of nearby residues that potentially
interact with FliM. In order to assess this possibility directly, the
crystal structure of CheY95IV was determined. We found that CheY95IV is structurally almost indistinguishable from wild-type CheY. Several other mutants with substitutions at position 95 were characterized to
establish the structural requirements for switch binding and clockwise
signaling at this position and to investigate a general relationship
between the two properties. The various rotational phenotypes of these
mutants can be explained solely by the amount of phosphorylated CheY
bound to the switch, which was inferred from the phosphorylation
properties of the mutant CheY proteins and their binding affinities to
FliM. Combined genetic, biochemical, and crystallographic results
suggest that residue 95 itself is critical in mediating the surface
complementarity between CheY and FliM.
Motile bacteria such as Escherichia coli respond to a
variety of environmental stimuli by modulating the rotational direction of their flagella. Counterclockwise
(CCW)1 rotation results in a
motion called smooth swimming, whereas a change to clockwise (CW)
rotation leads to tumbling of the bacterial cell. Chemotaxis toward
attractants or away from repellants is achieved by extending smooth
runs that carry the cell in the favorable direction. This swimming
behavior is controlled by the phosphorylation state of the response
regulator CheY. In its active, phosphorylated form, CheY exhibits
enhanced binding to a switch component, FliM, at the flagellar motor
that results in CW rotation. CheY is phosphorylated by the histidine
kinase CheA, whose activity depends on the signaling state of coupled
transmembrane chemoreceptors, and subsequently, is dephosphorylated
with the assistance of CheZ. In addition, CheY autophosphorylates using
small molecule phosphodonors and spontaneously dephosphorylates by its
intrinsic autophosphatase activity (for review, see Refs. 1-4).
CheY serves as a prototype for the investigation of response regulator
function in bacterial signal transduction. Although much has been
learned about its activation mechanism, the molecular basis of how the
interaction of CheY with the flagellar switch results in a reversal of
flagellar rotation is not yet known. A surface on CheY that interacts
with FliM has been deduced from genetic and biophysical studies.
Critical residues have been inferred from mutations in cheY
that suppress mutations in fliM (5-7) and from
investigating chemical shifts in NMR spectra of CheY upon binding to an
N-terminal peptide of FliM (8). It has been proposed that
Tyr106, located on the putative FliM binding face, plays a
major role in the interaction of CheY with the flagellar switch. The
side chain of Tyr106 was found in an inside conformation in
the crystal structure of an activated mutant, CheY106YW, and a
solvent-exposed, outside conformation in the structures of two
loss-of-function mutants, CheY87TI and CheY87TI106YW (9, 10). This
apparent correlation suggested that the conformation of residue 106 may
affect the signaling state of CheY. These and several other mutants
with substitutions at position 106, however, displayed unaltered FliM binding and phosphorylation properties in vitro compared
with wild-type CheY (11), which suggested that Tyr106
participates in a signaling step subsequent to binding to the switch
(10, 11). Recent crystallographic studies of the phosphorylated forms
of two other response regulators, FixJ from Rhizobium
meliloti (12) and SpoOA from Bacillus subtilis (13),
support the notion that the conformation of the conserved
phenylalanine/tyrosine residue (corresponding to Tyr106 in
CheY) is important in determining the signaling state of this class of proteins.
Characterization of another hyperactive mutant, CheY95IV, suggested a
role for Ile95 in switch interaction (14). The
phosphorylation-dependent constitutive signaling of this mutant
correlated with enhanced binding to FliM in vitro, thus
providing a likely explanation for its phenotype. Ile95
might directly interact with the switch or alter the nearby proposed FliM binding surface. Alternatively, it might influence the side chain
conformation of the adjacent residue Tyr106. To address
these possibilities directly, and to explore a general relationship
between switch binding and signaling, we determined the crystal
structure of CheY95IV and characterized several additional CheY mutants
with single site substitutions at position 95.
Bacterial Strains, Plasmids, and Mutant Constructions--
The
E. coli Behavioral Assay--
Cells were prepared for tethering as
described (14, 20). The cells, tethered to a glass slide, were analyzed
under a dark-field microscope, which was connected to a fully automated
video analysis and image processing system (Hobson Tracking Systems
Ltd., Sheffield, United Kingdom). The Hobson Tracker Arot software
determines the rotational direction of tethered cell bodies by
analyzing single video images generated at 60 Hz. The rotational
direction is defined by the relative movement of the center of mass
around the center of rotation, which the software assigns to each
selected cell. This particular method restricted analysis to individual
bacteria that were tethered at or near the poles of their cell bodies. For each strain, the behavior of a number of cells was quantified in
real time for 1 min each; and the raw data from the Hobson tracker
output files were converted into a bias value using a program written
by Matthew Levin (University of Cambridge, United Kingdom). The
rotational bias was defined to be the arithmetic mean of the fraction
of time all observed cells of a particular strain spent in the CCW
spinning mode. Individual cells pausing more than 5% of the total
recorded time were excluded from the calculation of a final bias.
Protein Purification and Peptide Synthesis--
E.
coli wild-type and mutant CheY proteins were purified from
overexpressing strains as described previously (21). Concentrations were determined with the Bio-Rad DC colorimetric assay. The FliM peptide corresponding to the N-terminal 16 residues of FliM
(MGDSILSQAEIDALLN), purified to a minimum chromatographic homogeneity
of 90%, was obtained from Macromolecular Resources (Fort Collins, CO).
Protein Phosphorylation Assays--
Fluorescence measurements of
CheY phosphorylation reactions were performed as described by
Silversmith et al. (22). Excitation and emission slit widths
of the spectrofluorimeter were adjusted to accommodate the respective
protein concentrations in the different assays. Time courses of
approach to steady-state phosphorylation that yielded an observed rate
constant (kobs) were performed at 17 °C. The
reactions were carried out in 100 mM HEPES, pH 7.0, and 10 mM MgCl2. For these measurements, 1.6 µM CheY (wild-type or mutant) was mixed with the
phosphodonor phosphoramidate (PAM) to give a final concentration of 100 mM. PAM was synthesized as described previously (23). The
values measured at 17 °C were converted to
kobs values at 25 °C using the Arrhenius
equation and assuming an activation energy for
kobs of 13.9 kcal/mol (22). Time courses that
yielded autodephosphorylation rate constants (kdephos) were measured at 25 °C, using a
published pH jump assay (24). This assay takes advantage of the pH
dependence of the CheY phosphorylation reaction when PAM serves as a
phosphodonor (22). At sufficiently high pH, CheY phosphorylation is
eliminated and the time course of approach to steady state therefore
only reflects the pH-independent dephosphorylation of CheY-P. We
incorporated the following modifications: A solution containing 20 µM CheY (wild-type or mutant) and 50 mM PAM
in 5 mM Tris, pH 7.0, and 10 mM
MgCl2 was mixed 1:1 with a concentrated high pH buffer
containing 150 mM CAPS, pH 10.5. MgCl2 and PAM
were omitted from this buffer to reduce precipitation problems.
The kinetic results were analyzed according to a reaction scheme by
Lukat et al. (25). Under the reaction conditions used here,
CheY phosphorylation by PAM can be treated as a first order reaction
with respect to the phosphodonor concentration with no indication of
saturation at high substrate concentrations (24, 26).
kobs can therefore be expressed as follows:
It should be noted that CheY95IA exhibited a significantly lower
fluorescence quench compared with wild-type CheY when equilibrium phosphorylation had been reached after addition of 100 mM
PAM. This difference, however, did not reflect significant differences in the fraction of phosphorylated CheY present in the reaction, because
the measured rate constants, kobs and
kdephos, were almost identical to those of
wild-type CheY. The discrepancy is therefore probably due to
differences in the fluorescence properties of the two CheY proteins.
Equilibrium titrations with CheZ were performed at 25 °C in a buffer
containing 100 mM HEPES, pH 7.0, and 10 mM
MgCl2. 5.0 µM CheY (wild-type or mutant) was
phosphorylated with 100 mM PAM. After equilibrium
phosphorylation had been reached, increasing amounts of CheZ were
added. The progress of the dephosphorylation reactions was plotted as
the relative increase in fluorescence intensity versus the
total CheZ concentration.
Binding Assay--
Measurement of the binding affinities between
CheY mutant proteins and FliM peptide was based on a fluorimetric assay
described by McEvoy et al. (8). 10 µM CheY
(wild-type or mutant) was titrated with repetitive additions of FliM
peptide in 100 mM HEPES, pH 7.0, and 10 mM
MgCl2 while monitoring tryptophan fluorescence. For
titrations with phosphorylated CheY, 100 mM PAM was added to the sample. Buffer conditions were chosen to be identical to those
in the kinetic experiments. It should be pointed out that, in contrast
to the assay by McEvoy et al., Mg2+ was present
in the binding reactions even in the absence of PAM. Binding constants
were determined using Eadie-Hofstee analysis, assuming a single binding
site on CheY for FliM peptide and considering the concentration of free
ligand in the binding reaction. To estimate the fraction of free ligand
versus ligand bound to CheY, the maximum fluorescence change
when all of CheY is converted into complex ( Protein Crystallization--
The purified CheY95IV protein was
concentrated to 22 mg/ml in H2O with a Centricon 10 concentrator (Amicon) for crystallization trials. Initially, 50 different crystallization conditions from a commercially available kit
(Crystal Screen from Hampton Research, Laguna Niguel, CA) were screened
using the hanging drop vapor diffusion method (27) at 4 °C. Each
droplet contained 1 µl of protein solution and 1 µl of reservoir
solution. Long needles were obtained from a solution containing 0.19 M ammonium sulfate, 0.10 M sodium acetate, pH
4.8, and 25% polyethylene glycol 4000. These crystals were used to
microseed a solution containing 0.17 M ammonium sulfate,
0.09 M sodium acetate, pH 4.8, and 23% polyethylene glycol
4000, which yielded diffraction quality crystals with dimensions of
0.7 × 0.1 × 0.04 mm. Crystal seeds were obtained by
100-fold dilution of seed stock prepared with the Seed Bead kit from
Hampton Research (Laguna Niguel, CA).
Crystallographic Data Collection, Structural Determination, and
Refinement--
Crystals of CheY95IV were transferred to mother liquor
plus 10% glycerol and were immediately placed in a cryogenic nitrogen stream (100 K, Oxford Cryo System). Diffraction data were collected using an R-Axis IIC area detector, and they were processed using programs Denzo and Scalepack (28). These crystals were nearly isomorphous to the crystals of wild-type E. coli CheY (29). Data statistics are shown in Table I.
The structure of CheY95IV was determined using the Molecular
Replacement method with the wild-type E. coli CheY structure at 1.7-Å resolution (29) as a model. Alanine was substituted for
Tyr106 to avoid potential model bias. Because CheY95IV
crystallized nearly isomorphously to wild-type CheY, the position and
orientation of the wild-type structure was used to begin refinement of
CheY95IV. Rigid body refinement in CNS (30) was applied to refine the position and orientation of the molecule in the asymmetric unit. The
first electron density maps were generated using DM (31). Manual model
building was performed with O (32), and refinement was performed with
CNS (30). After refinement converged with Rfree = 30.5% and Rwork = 29.2%, water molecules
were added with Arp (33) and were visually confirmed. Three sulfate
clusters were modeled in the map and were used in the refinement. The
final refinement statistics are shown in Table I. Over 95% of the
residues belong to the most favored region in a Ramachandran plot (34). No residues are in the generously allowed region. However, one residue
(Asn62) falls into the disallowed region ( Behavioral Analysis of CheY Mutants--
To assess the structural
requirements of residue 95 in CheY that are necessary to cause
hyperactive signaling, several amino acid substitutions at position 95 were generated. The tethered cell assay was used to quantify the
behavior of bacteria expressing these mutant alleles (Table
II). As reported previously, the
cheY95IV allele results in extreme CW behavior when
expressed from a multicopy plasmid in a Phosphorylation Kinetics--
Next, a possible correlation between
switch binding and signaling was explored. We selected activated
mutants CheY95IA and CheY95IV, as well as one representative of the
loss-of-function mutants, CheY95IM, to determine their binding
affinities to a peptide of FliM in vitro. To quantify FliM
binding of these CheY mutants in their phosphorylated forms, it was
critical to determine the fraction of CheY phosphorylated in each
binding reaction. Dissociation constants were calculated based on the
fraction of free ligand (i.e. FliM peptide) present in the
reaction, which was deduced by subtracting the amount of ligand bound
to protein (i.e. phosphorylated- or nonphosphorylated CheY)
from the total amount of ligand added. Toward this goal, the
autophosphorylation and autodephosphorylation properties of each CheY
mutant protein were characterized using tryptophan fluorescence (Table
III).
The experimentally determined rate constants
(kobs and kdephos)
for wild-type CheY resemble those obtained by Mayover et al. (24) under comparable conditions. Mutants CheY95IA and CheY95IV exhibited phosphorylation kinetics that yielded rate constants almost
identical to those of wild-type CheY, leading to similar fractions of
phosphorylated protein. Notably, CheY95IM displayed 2-fold enhanced
autophosphorylation compared with wild-type, which, however, had little
impact on the fraction of phosphorylated CheY95IM.
FliM Binding--
The binding affinities of various mutant CheY
proteins to FliM were probed by monitoring quenching of intrinsic
tryptophan fluorescence in CheY upon binding to a peptide of FliM in
the presence and absence of PAM (8) (Fig.
1, A and B). This
peptide, containing the N-terminal 16 amino acids of FliM, has been
shown to specifically bind to CheY in a
phosphorylation-dependent manner (36). Wild-type CheY
exhibited about 11-fold tighter binding in the presence of PAM compared
with the reaction without phosphodonor (Fig. 1C).
Hyperactive mutant CheY95IV showed about 3- and 7-fold enhanced binding
in the absence and presence of PAM compared with the respective
reactions with wild-type CheY, which was more pronounced than
previously observed in a cross-linking assay using intact FliM (14).
For another hyperactive mutant, CheY95IA, however, no specific binding
of FliM peptide could be detected in the absence of PAM (within the
sensitivity of this assay), and even with PAM present, binding was
5-fold lower than that of wild-type CheY in the presence of PAM. In
contrast to CheY95IV, the weaker peptide binding observed for CheY95IA
therefore did not correlate with its enhanced CW flagellar rotation.
CheY95IM also exhibited negligible binding to FliM peptide under both
nonphosphorylating and phosphorylating conditions, consistent with its
exclusively CCW behavior. The constitutively active mutants CheY13DK
(15, 37) and CheY13DK106YW (38) were included in this assay to compare
their binding affinities to FliM peptide with those obtained in
previous assays using purified, intact FliM (39, 40). This allowed us
to assess how accurately binding of the various CheY mutants to FliM
peptide reflects binding to full length FliM in vitro.
Description of Structural Results--
To investigate the
structural basis for the constitutive signaling and enhanced FliM
binding properties of CheY95IV (14), the x-ray structure of this mutant
protein was determined to 1.9-Å resolution. The structure of CheY95IV
is well resolved in the final electron density map as evidenced by the
92.7% real space correlation coefficient (32). The overall structure
is indistinguishable from that of wild-type E. coli apo-CheY
(29). A least-squares superposition of the C
Previous studies have suggested that the conformation of
Tyr106 plays an important role in signal transduction by
CheY (10, 11). The side chain of residue Tyr106 is found in
two conformations in the wild-type CheY structure (29), one occupying a
hydrophobic cavity, the other pointing out to the solvent. In CheY95IV,
the electron density for the outside conformation of Tyr106
is well defined (Fig. 2). Because the side chain of Tyr106
was deleted during the entire structural determination and refinement process (except for the last cycle), this density distribution is not a
result of model bias, which was confirmed with a simulated annealing
omit map (42, 43). A small patch of electron density is found in the
inside pocket (Fig. 2), which is currently modeled as two water
molecules. In the wild-type CheY structure, the electron densities for
both the inside and outside conformations of Tyr are well defined (29).
However, the bond angle between C The Significance of the Conformation of Tyr106 in
Switch Interaction--
The Tyr106 side chain in CheY can
occupy two orientations, a solvent-exposed outside or a
solvent-inaccessible inside position where it is packed in the interior
of a hydrophobic pocket (10, 29). Our crystallographic results show
that, in the structure of CheY95IV, Tyr106 is restricted to
the outside conformation (Fig. 2). It is not clear what leads to this
position as opposed to the dual conformation in wild-type CheY (29),
because the extra CD1 atom of isoleucine in the wild-type structure
does not have any direct interaction with Tyr106. One
possible explanation is that the inside conformation of Tyr106 in the wild-type structure is highly strained. The
change from an isoleucine to a slightly smaller valine at position 95 may have enabled the tyrosine ring to swing out more easily to avoid the highly strained inside conformation. However, it is puzzling why
Tyr106 would adopt the inside conformation in the wild-type
structure at all.
The conformational heterogeneity of the Tyr106 side chain
has been suggested to correlate with the activation state of CheY, where in the simplest model "in" reflects the active form and "out" the inactive form (10). The structure and phenotype of CheY95IV seemingly argue against this model. One needs to consider, however, that the mutant structures CheY87TI, CheY87TI106YW, and CheY106YW on which this model has been based as well as the structure of CheY95IV resemble the nonphosphorylated, presumably inactive form of
CheY. After completion of the present study, high resolution structures
of the phosphorylated forms of two other response regulators were
published (12, 13). In both cases, relocation of the conserved
threonine to interact directly with the phosphoryl group on the
conserved aspartate caused a coordinated reorientation of the conserved
phenylalanine/threonine (Tyr106 in CheY) from the outside
to the inside conformation. The same coupled rearrangement was observed
in the very recently completed NMR structure of
beryllofluoride-activated CheY (44). It is very likely that
Tyr106 in phosphorylated CheY95IV adopts the inside
conformation as well, because the structure of the nonphosphorylated
form shows no alterations of active site residues that could
impair the aforementioned coupled rearrangement upon phosphorylation.
Residue 95 Mediates the Surface Complementarity between CheY and
FliM--
CheY95IV exhibited enhanced binding to FliM peptide in both
the phosphorylated and nonphosphorylated forms (Fig. 1). In the crystal
structure of CheY95IV (which represents the nonphosphorylated form) no
changes occurred at the proposed FliM binding surface. The altered
conformation of Tyr106 was the only significant change
compared with wild-type CheY besides the substitution at position 95 itself (Fig. 2). In the active, phosphorylated form, the tyrosine side
chain is probably buried in the interior of a hydrophobic pocket (as
discussed above) and therefore does not affect FliM binding. This is
supported by the unaltered FliM binding affinities of CheY mutants with substitutions at position 106 (11). Mutants with substitutions at
position 95, on the other hand, do have a dramatic impact on the
binding affinity of CheY to FliM peptide (Fig. 1). Taken together, these findings suggest that Ile95 itself directly interacts
with FliM. In maintaining the structural integrity of the switch
binding surface on CheY, replacement of isoleucine with the slightly
smaller valine might enhance the complementarity between the two
proteins, allowing neighboring residues to bind to FliM more tightly.
The solvent-exposed nature of the 95 side chain on The Various Phenotypes of CheY Mutants with Substitutions at
Position 95 Can Be Explained by the Amount of Phosphorylated CheY Bound
to the Switch--
Our behavioral studies demonstrated that
substitutions at position 95 in CheY have a large impact on the cell's
behavioral phenotype: One class of mutants with aspartate, glycine,
lysine, and methionine substitutions completely lost its CW signaling ability, whereas the other class containing alanine and valine substitutions displayed increased CW signaling (Table II). The various
substitutions at position 95 also affected the FliM-peptide binding
affinities of all CheY mutants tested (Fig. 1C). The greatly impaired binding of one candidate from the first class, CheY95IM, correlated with its loss of CW signaling ability. This may be due to
the bulk of the longer hydrophobic side chain of methionine in the
mutant compared with isoleucine in wild-type CheY, which could
interfere with the surface complementarity between CheY and FliM.
Similarly, it can be envisioned that the positive and negative surface
charges introduced by the lysine and alanine substitutions in CheY95IK
and CheY95ID impair binding to FliM, resulting exclusively in CCW
signaling. For the hyperactive mutants, interpretation of the results
is more complicated: The shorter nonpolar side chains, valine and
alanine, in CheY95IV and CheY95IA both promoted enhanced CW signaling,
but this hyperactivity apparently did not correlate with the decreased
FliM binding affinity shown by CheY95IA.
It must be considered that our FliM-peptide binding assay may not
provide a complete assessment of the interactions between CheY-P and
the flagellar switch complex in vivo. It has been suggested that there are parts of full length FliM not represented by the peptide
that interact with CheY (46). Our results, however, showed that binding
of CheY to FliM peptide (Fig. 1C) qualitatively reflects
binding to intact, purified FliM measured by in vitro cross-linking (14, 39) or bead binding (40). This agreement is true for
all proteins (wild-type CheY, CheY13DK, CheY95IV, and CheY13DK106YW)
that have been assayed by both peptide and full length FliM and extends
to the relative affinities among different mutants as well as the
effects of phosphorylation on binding.
The possibility remains that, in addition to FliM binding, altered
phosphorylation properties affecting phosphotransfer from CheA or
sensitivity to CheZ contributed to the phenotypes of the various CheY
mutants characterized here. For the activated mutants CheY95IA and
CheY95IV, reduced CheZ sensitivity could potentially increase the
concentration of phosphorylated CheY in the cell thereby leading to a
stronger CW bias. Enhanced phosphotransfer from CheA, on the other
hand, would have virtually no impact on cellular CheY-P levels, because
this step is not rate-limiting (47). These explanations do not apply to
CheY95IV, because both reactions are similar to those of wild-type CheY
(14). In addition, we measured the CheZ sensitivity of CheY95IA by
following the relative increase in fluorescence intensity due to
dephosphorylation of CheY-P upon titration with CheZ. Compared with
wild-type CheY, CheY95IA exhibited no increase in fluorescence even at
levels of CheZ that were saturating for wild-type CheY (data not
shown). This indicated that CheY95IA is resistant to the phosphatase
activity of CheZ. The phenotype of this mutant can therefore be
reconciled with its binding affinity to FliM, if the impact of CheZ on
the phosphorylation state of CheY95IA in vivo is considered.
Complete insensitivity of CheY95IA to dephosphorylation mediated by
CheZ would be similar to a situation in the cell where CheZ is
completely lacking. In such strains, the fraction of wild-type CheY
phosphorylated has been estimated to be greater than 99.9%, compared
with only about 30% in the presence of CheZ (48). We can therefore
assume that the concentration of CheY95IA-P in the cell is more than 3-fold higher than in wild-type CheY-P. This compensates enough for the
observed 5-fold lower binding to FliM that there is no compelling
reason to postulate any other effect on the behavioral phenotype of
this mutant, given the margin of error in the underlying measurements
and the nonlinear relationship between switch-bound CheY-P and
rotational bias.
Therefore, these results suggested that the various phenotypes of
mutants with substitutions at position 95 are due to their binding
affinities to FliM and the respective CheY-P levels in the cell, both
of which determine the amount of CheY-P molecules bound to the switch.
This is in accordance with a recent study (38) that established a
functional relationship between the probability of CW or CCW flagellar
rotation and the fraction of switch binding sites occupied by CheY-P.
For mutants with substitutions at position 95, there is no need to
postulate a postbinding step as proposed for other mutants with
substitutions at position 106 (10, 11).
We thank Ruth Silversmith for biochemical
support, Megan McEvoy for providing information about the FliM-peptide
binding assay prior to publication, and Karl Volz for his advice on
CheY crystallization. We are indebted to Ed Westbrook and Phil
Matsumura for providing information about a cocrystal of CheY bound to
FliM peptide prior to publication.
*
This work was supported by National Institutes of Health
Grant GM50860 (to R. B. B.), and by a Cancer Research Institute
Fellowship (to R. Z. ).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
The atomic coordinates and the structure factors (code 1D4Z) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).
Published, JBC Papers in Press, March 29, 2000, DOI 10.1074/jbc.M909908199
2
E. M. Westbrook and P. Matsumura, personal communication.
The abbreviations used are:
CCW, counterclockwise;
CW, clockwise;
CheY-P, phosphorylated CheY;
PAM, phosphoramidate;
CAPS, 3-(cyclohexylamino)propanesulfonic acid.
Correlated Switch Binding and Signaling in Bacterial
Chemotaxis*
, and
![]()
ABSTRACT
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
![]()
MATERIALS AND METHODS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
(cheY)m60-21 strain
KO641recA, the
(cheA)m102-11 strain
RBB382, and the ptrp cheYZ plasmid pRBB40 have
been described (15). Derivatives of pRBB40 carrying the cheY
alleles 13DK (15) or 95IV (16) also have previously been reported. In
this work, versions of pRBB40 carrying the cheY alleles
95IA, 95ID, 95IK, or 95IM were constructed using dut ung
mutagenesis (15, 17); cheY allele 95IG was constructed using
splicing by overlap-extension polymerase chain reaction (18, 19), and cheY allele 13DK106YW was constructed by recombining
appropriate restriction fragments in vitro using standard
techniques. All mutations were confirmed by sequencing the entire
cheY genes of the various pRBB40 plasmids.
The quantity of
(kphos/KS)[PAM]
represents an effective rate constant for phosphorylation. Although the
autophosphorylation rate constant kphos and the
dissociation constant of the CheY-PAM enzyme-substrate complex
KS are unknown,
(kphos/KS)[PAM] can be measured as the difference between kobs and
kdephos (Eq. 1). The ratio of
(kobs
(Eq. 1)
kdephos) to
kdephos yields the ratio of phosphorylated to
unphosphorylated CheY present in the binding reaction.
Imax), was extrapolated by fitting the
titration data to a hyperbolic binding function. Interfering
fluorescence from the addition of FliM peptide, probably due to
residual organic solvents, became significant (maximal 10%) at high
peptide concentrations and was considered in the overall calculation.
Summary of crystallographic analysis
= 68.60,
=
60.80) in the Ramachandran plot. The conformation of this
residue is justified by the existence of a hydrogen bond between the
ND2 atom of Asn62 and the OD2 atom of Asp38.
Protein residues have occasionally been observed to have
and
angles in this region (35).
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
cheY
host and maintains this phenotype when expressed from a single copy
gene on the chromosome (14). In this study, Ile95 was
replaced with alanine, which created a CheY mutant that also showed
more CW behavior than wild-type. The smaller nonpolar residues valine
and alanine therefore promoted enhanced CW signaling ability. In
contrast, the complete lack of a side chain at position 95 (i.e. CheY95IG) did not support CW rotation. Similarly, the
presence of a larger hydrophobic side chain in CheY95IM, as well as
charge substitutions in CheY95ID and CheY95IK, also resulted in loss of
activity. In addition, we tested the CW signaling ability of these
mutants in a
cheA host (data not shown). All CheY mutants failed to support CW rotation, implying that phosphorylation is necessary for their activation.
Behavioral characterization of CheY mutants
Kinetic characterizationa of mutant CheY proteins

View larger version (18K):
[in a new window]
Fig. 1.
Binding of FliM peptide to CheY mutants.
A and B, titration curves of wild-type CheY (
,
), CheY95IA (
,
), CheY95IM (
,
), and CheY95IV (
,
)
in the presence and absence of PAM (filled and open
symbols, respectively). The relative decrease in fluorescence
intensity upon sequential addition of FliM peptide is shown. The data
were fit to a hyperbolic binding function. Note the different scales on
the abscissas in A and B. The inset in
A shows Eadie-Hofstee plots, which were used to determine
dissociation constants (KD). The slope of a
linear fit to the data yielded KD. C,
calculated binding affinities. The values shown in the bar
graph represent the reciprocal of the respective
KD values normalized to the
KD of wild-type CheY in the absence of
phosphodonor. White bars denote the absence, and black
bars denote the presence of PAM. Binding reactions for CheY13DK
and CheY13DK106YW were carried out in the absence of PAM but displayed
in black bars because both proteins presumably represent the
activated conformation (37, 38).
atoms of
the two structures yielded a root mean square deviation of 0.21 Å,
which is not significantly different from the 0.18-Å coordinate error
obtained with the maximum likelihood refinement program REFMAC (41).
The conformations of active site residues are identical between the two
structures. Residues Arg19, Glu34,
Lys45, Glu67, Lys92, and
Glu118 have minor side chain differences between the
CheY95IV and wild-type structures. All of these residues have long and
flexible side chains and are located on the external surface of CheY.
Although the crystals of wild-type and mutant CheY are of the same
space group, they form under different conditions; the aforementioned surface residues therefore presumably adopt different side chain conformations to adapt to the different environments. These minor differences do not seem to affect the rest of the structure or have any
obvious biological consequences. The side chains of three residues
(Glu37, Ser56, and Leu127) are
modeled as two discrete rotamers as they are found in the wild-type
structure. Four residues (Glu23, Asn32,
Met85, and Tyr106), which have multiple
conformations in wild-type CheY only demonstrate single side chain
conformations in CheY95IV. Two other residues in the mutant structure
(residues Glu27 and Val95) have double
conformations. As expected, the 2Fo
Fc map and the simulated annealing omit map (42,
43) both demonstrate electron densities appropriate for a valine at
position 95 (not shown). These maps, together with the difference map,
also indicate that Val95 exists in two distinct
conformations (Fig. 2). Among the
residues that are within 10 Å from Val95, the only notable
differences from the wild-type structure come from the side chains of
Tyr106 and Glu27 of a symmetry-related
molecule.

View larger version (33K):
[in a new window]
Fig. 2.
Residue Tyr106 predominantly
adopts the outside conformation in CheY95IV instead of the double
conformations seen in the wild-type structure (10). Shown here is
a stereo view of the final 2Fo
Fc electron density map (contoured at 1
) of
the Tyr106 side chain for the structure of CheY95IV. The
outside conformation of Tyr106 in CheY95IV fits well in
this density (shown in black). For comparison, the inside
conformation from the wild-type structure is displayed in
red. Note that this conformation has a strained
C
-C
-C
angle of 135°,
which is roughly 20° off the ideal value for this bond angle.
Val95 is shown in its two conformations (green
and black lines) as inferred from the electron density at
this position.
, C
, and
C
in the inside position is significantly distorted (20o off the ideal bond angle). The density in the pocket
of CheY95IV, in contrast, is very small compared with a phenol ring,
and even after significant distortion of the bond angle between
C
, C
, and C
, only the CD2
and CE2 atoms of the phenol ring fit this density. Although we cannot
completely rule out the possibility that in a small population of CheY
molecules Tyr106 assumes this strained conformation, it is
clear that Tyr106 predominantly points outward. It can also
be excluded that residues from a symmetry-related molecule located in
the vicinity of Tyr106 have any more influence on the
position of Tyr106 in CheY95IV than in the isomorphous
wild-type structure. In summary, the only significant differences
between wild-type CheY and CheY95IV are an almost isosteric change from
isoleucine to valine at position 95 and the predominant outside
conformation of Tyr106.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
-helix 4, which
has been implicated in the signal transmission through hydrophobic
interactions in other response regulators (12, 45), is consistent with
this function. Although NMR studies provided no evidence for the direct
interaction of Ile95 with FliM peptide (8), the cocrystal
structure of a CheY mutant bound to FliM peptide showed that the
peptide binds very close to Ile95, supporting our
conclusion.2
![]()
ACKNOWLEDGEMENTS
![]()
FOOTNOTES
To whom correspondence should be addressed: Tel.: 919-966-2679;
Fax: 919-962-8103; E-mail: bourret@med.unc.edu.
![]()
ABBREVIATIONS
![]()
REFERENCES
TOP
ABSTRACT
INTRODUCTION
MATERIALS AND METHODS
RESULTS
DISCUSSION
REFERENCES
1.
Eisenbach, M.
(1996)
Mol. Microbiol.
20,
903-910
2.
Macnab, R. M.
(1996)
in
Escherichia coli and Salmonella: Cellular and Molecular Biology
(Neidhardt, F. C.
, Curtiss, R., III
, Ingraham, J. L.
, Lin, E. C. C.
, Low, K. B.
, Magasanik, B.
, Reznikoff, W. S.
, Riley, M.
, Schaechter, M.
, and Umbarger, H. E., eds), 2nd Ed.
, pp. 123-145, ASM Press, Washington, DC
3.
Stock, J. B.,
and Surette, M. G.
(1996)
in
Escherichia coli and Salmonella: Cellular and Molecular Biology
(Neidhardt, F. C.
, Curtiss, R., III
, Ingraham, J. L.
, Lin, E. C. C.
, Low, K. B.
, Magasanik, B.
, Reznikoff, W. S.
, Riley, M.
, Schaechter, M.
, and Umbarger, H. E., eds), 2nd Ed.
, pp. 1103-1129, ASM Press, Washington, DC
4.
Silversmith, R. E.,
and Bourret, R. B.
(1999)
Trends Microbiol.
7,
16-21
5.
Sockett, H.,
Yamaguchi, S.,
Kihara, M.,
Irikura, V. M.,
and Macnab, R. M.
(1992)
J. Bacteriol.
174,
793-806
6.
Roman, S. J.,
Meyers, M.,
Volz, K.,
and Matsumura, P.
(1992)
J. Bacteriol.
174,
6247-6255
7.
Shukla, D.,
Zhu, X. Y.,
and Matsumura, P.
(1998)
J. Biol. Chem.
273,
23993-23999
8.
McEvoy, M. M.,
Bren, A.,
Eisenbach, M.,
and Dahlquist, F. W.
(1999)
J. Mol. Biol.
289,
1423-1433
9.
Ganguli, S.,
Wang, H.,
Matsumura, P.,
and Volz, K.
(1995)
J. Biol. Chem.
270,
17386-17393
10.
Zhu, X.-Y.,
Rebello, J.,
Matsumura, P.,
and Volz, K.
(1997)
J. Biol. Chem.
272,
5000-5006
11.
Zhu, X.,
Amsler, C. D.,
Volz, K.,
and Matsumura, P.
(1996)
J. Bacteriol.
178,
4208-4215
12.
Birck, C.,
Mourey, L.,
Gouet, P.,
Fabry, P.,
Schumacher, J.,
Rousseau, P.,
Kahn, D.,
and Samama, J.-P.
(1999)
Structure
7,
1505-1517
13.
Lewis, R. J.,
Brannigan, J. A.,
Muchova, K.,
Barak, I.,
and Wilkinson, A. J.
(1999)
J. Mol. Biol.
294,
9-15
14.
Schuster, M.,
Abouhamad, W. N.,
Silversmith, R. E.,
and Bourret, R. B.
(1998)
Mol. Microbiol.
27,
1065-1075
15.
Bourret, R. B.,
Hess, J. F.,
and Simon, M. I.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
41-45
16.
Sanna, M. G.,
Swanson, R. V.,
Bourret, R. B.,
and Simon, M. I.
(1995)
Mol. Microbiol.
15,
1069-1079
17.
Kunkel, T. A.,
Roberts, J. D.,
and Zakour, R. A.
(1987)
Methods Enzymol.
154,
367-382
18.
Ho, S. N.,
Hunt, H. D.,
Horton, R. M.,
Pullen, J. K.,
and Pease, L. R.
(1989)
Gene
77,
51-59
19.
Horton, R. M.
(1995)
Mol. Biotechnol.
3,
93-99
20.
Bray, D.,
Bourret, R. B.,
and Simon, M. I.
(1993)
Mol. Biol. Cell
4,
469-482
21.
Hess, J. F.,
Bourret, R. B.,
and Simon, M. I.
(1991)
Methods Enzymol.
200,
188-204
22.
Silversmith, R. E.,
Appleby, J. L.,
and Bourret, R. B.
(1997)
Biochemistry
36,
14965-14974
23.
Sheridan, R. C.,
McCullough, J. F.,
and Wakefield, Z. T.
(1972)
Inorg. Synth.
13,
23-26
24.
Mayover, T. L.,
Halkides, C. J.,
and Stewart, R. C.
(1999)
Biochemistry
38,
2259-2271
25.
Lukat, G. S.,
McCleary, W. R.,
Stock, A. M.,
and Stock, J. B.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
718-722
26.
Da Re, S. S.,
Deville-Bonne, D.,
Tolstykh, T.,
Veron, M.,
and Stock, J. B.
(1999)
FEBS Lett.
457,
323-326
27.
Wlodawer, A.,
and Hodgson, K. O.
(1975)
Proc. Natl. Acad. Sci. U. S. A.
72,
398-399
28.
Otwinowski, Z.,
and Minor, W.
(1996)
Methods Enzymol.
276,
307
29.
Volz, K.,
and Matsumura, P.
(1991)
J. Biol. Chem.
266,
15511-15519
30.
Brunger, A. T.,
Adams, P. D.,
Clore, G. M.,
DeLano, W. L.,
Gros, P.,
Grosse-Kunstleve, R. W.,
Jiang, J.-S.,
Kuszewski, J.,
Nilges, M.,
Pannu, N. S.,
Read, R. J.,
Rice, L. M.,
Simonson, T.,
and Warren, G. L.
(1998)
Acta Crystallogr. Sect. D Biol. Crystallogr.
54,
905-921
31.
Dodson, E. J.,
Winn, M.,
and Ralph, A.
(1998)
Methods Enzymol.
277,
620-633
32.
Jones, T. A.,
Zou, J.-Y.,
Cowan, S. W.,
and Kjeldgaard, M.
(1991)
Acta Crystallogr. Sect. A
47,
110-119
33.
Lamzin, V. S.,
and Wilson, K. S.
(1997)
Methods Enzymol.
277,
269-305
34.
Ramachandran, G. N.,
and Sasisekharan, V.
(1968)
Adv. Protein Chem.
23,
283-437
35.
Betts, L. S.,
Xiang, S. A.,
Short, S. A.,
Wolfenden, R.,
and Carter, C. W. J.
(1994)
J. Mol. Biol.
235,
635-656
36.
Bren, A.,
and Eisenbach, M.
(1998)
J. Mol. Biol.
278,
507-514
37.
Bourret, R. B.,
Drake, S. K.,
Chervitz, S. A.,
Simon, M. I.,
and Falke, J. J.
(1993)
J. Biol. Chem.
268,
13089-13096
38.
Scharf, B. E.,
Fahrner, K. A.,
Turner, L.,
and Berg, H. C.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
201-206
39.
Scharf, B. E.,
Fahrner, K. A.,
and Berg, H. C.
(1998)
J. Bacteriol.
180,
5123-5128
40.
Welch, M.,
Oosawa, K.,
Aiziwa, S.-I.,
and Eisenbach, M.
(1994)
Biochemistry
33,
10470-10476
41.
Murshudov, G. N.,
Vagin, A. A.,
and Dodson, E. J.
(1997)
Acta Crystallogr. Sect. D Biol. Crystallogr.
53,
240-255
42.
Hodel, A.,
Kim, S.-H.,
and Brunger, A. T.
(1992)
Acta Crystallogr. Sect. A.
48,
851-859
43.
Brunger, A. T.,
Adams, P. D.,
and Rice, L. M.
(1997)
Structure
5,
325-336
44.
Cho, H. S.,
Lee, S.-Y.,
Yan, D.,
Pan, X.,
Parkinson, J. S.,
Kustu, S.,
Wemmer, D. E.,
and Pelton, J. G.
(2000)
J. Mol. Biol.
297,
543-551
45.
Kern, D.,
Volkman, B. F.,
Luginbuhl, P.,
Noahile, M. J.,
Kustu, S.,
and Wemmer, D. E.
(1999)
Nature
402,
894-898
46.
Mathews, M. A. A.,
Tang, H. L.,
and Blair, D. F.
(1998)
J. Bacteriol.
180,
5580-5590
47.
Stewart, R. C.
(1997)
Biochemistry
36,
2030-2040
48.
Alon, U.,
Camarena, L.,
Surette, M. G.,
Aguera y Arcas, B.,
Liu, Y.,
Leibler, S.,
and Stock, J. B.
(1998)
EMBO J.
17,
4238-4248
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
M. C. Lane, A. N. Simms, and H. L. T. Mobley Complex Interplay between Type 1 Fimbrial Expression and Flagellum-Mediated Motility of Uropathogenic Escherichia coli J. Bacteriol., August 1, 2007; 189(15): 5523 - 5533. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Porter, G. H. Wadhams, A. C. Martin, E. D. Byles, D. E. Lancaster, and J. P. Armitage The CheYs of Rhodobacter sphaeroides J. Biol. Chem., October 27, 2006; 281(43): 32694 - 32704. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. I. Varughese Conformational Changes of Spo0F along the Phosphotransfer Pathway J. Bacteriol., December 15, 2005; 187(24): 8221 - 8227. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Szurmant and G. W. Ordal Diversity in Chemotaxis Mechanisms among the Bacteria and Archaea Microbiol. Mol. Biol. Rev., June 1, 2004; 68(2): 301 - 319. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Smith, J. A. Latiolais, G. P. Guanga, S. Citineni, R. E. Silversmith, and R. B. Bourret Investigation of the Role of Electrostatic Charge in Activation of the Escherichia coli Response Regulator CheY J. Bacteriol., November 1, 2003; 185(21): 6385 - 6391. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. E. Silversmith, G. P. Guanga, L. Betts, C. Chu, R. Zhao, and R. B. Bourret CheZ-Mediated Dephosphorylation of the Escherichia coli Chemotaxis Response Regulator CheY: Role for CheY Glutamate 89 J. Bacteriol., March 1, 2003; 185(5): 1495 - 1502. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Re, T. Tolstykh, P. M. Wolanin, and J. B. Stock Genetic analysis of response regulator activation in bacterial chemotaxis suggests an intermolecular mechanism Protein Sci., November 1, 2002; 11(11): 2644 - 2654. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. J. Im, S.-H. Rho, C.-M. Park, S.-S. Yang, J.-G. Kang, J. Y. Lee, P.-S. Song, and S. H. Eom Crystal structure of a cyanobacterial phytochrome response regulator Protein Sci., March 1, 2002; 11(3): 614 - 624. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bren and M. Eisenbach How Signals Are Heard during Bacterial Chemotaxis: Protein-Protein Interactions in Sensory Signal Propagation J. Bacteriol., December 15, 2000; 182(24): 6865 - 6873. [Full Text] |
||||
![]() |
R. E. Silversmith, J. G. Smith, G. P. Guanga, J. T. Les, and R. B. Bourret Alteration of a Nonconserved Active Site Residue in the Chemotaxis Response Regulator CheY Affects Phosphorylation and Interaction with CheZ J. Biol. Chem., May 18, 2001; 276(21): 18478 - 18484. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Schuster, R. E. Silversmith, and R. B. Bourret Conformational coupling in the chemotaxis response regulator CheY PNAS, May 22, 2001; 98(11): 6003 - 6008. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||